New obesity drug, Meridia

March 1998

Knoll is now shipping their new obesity drug, Meridia.

Meridia (sibutramine) suppresses appetite by inhibiting the reuptake of norepinephrine...serotonin...and to a lesser extent, dopamine.

This helps patients stick to a low calorie diet...leading to about a 5% to 10% weight loss.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote